Lentiviral vectors can be used for full-length dystrophin gene therapy. (2017)
Attributed to:
MICA: Development of gene therapy for the incurable inherited childhood epilepsy, Dravet Syndrome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/srep44775
PubMed Identifier: 28303972
Publication URI: http://europepmc.org/abstract/MED/28303972
Type: Journal Article/Review
Volume: 7
Parent Publication: Scientific reports
ISSN: 2045-2322